Abstract:Background Heart failure (HF) is a syndrome due to cardiac insufficiency, manifested by excessive volume overload, increased sympathetic activity, and circulatory redistribution [1]. Heart failure with preserved ejection fraction (HFpEF) accounts for approximately 40%-50% of the total HF events, and its development is often accompanied by various complications, including hypertension, obesity, and metabolic syndrome. Biomarker associations in heart failure with reduced ejection fraction were mostly cardiac stretch based, while many biomarkers of HFpEF are also associated with inflammation [2]. To date, treatments that effectively improve the clinical prognosis of HFpEF are relatively limited, thus HFpEF remains one of the challenges that needs to be further explored. A full understanding of the molecular mechanisms of HFpEF is essential to improve the early diagnosis, treatment and prognosis of these patients. Purpose The study aims to explore key circulating miRNAs and related molecular pathways in HFpEF patients through bioinformatics analysis and machine learning, and to further validate them using a double-hit HFpEF mouse model. Methods We downloaded HF datasets including circulating miRNA expression profiles from the GEO database. LASSO regression, SVM-RFE, Random Forest and XGboost algorithm were conducted to identify key miRNAs for diagnostic model construction. We used R software, GO, KEGG and Cytoscape to better understand the functions of key miRNA targets. Besides, the mRNA-miRNA interaction networks were predicted by starbase. We also constructed a HFpEF mouse model subjected to high fat diet and L-NAME (0.5 g/L) in drinking water to discover the correlation between the screened circulating miRNA and HFpEF. Results After differential expression analysis of the combined HFpEF dataset, we identified 37 differentially circulating miRNAs, of which 15 were down-regulated and 22 were up-regulated. Subsequently, we screened by machine learning and identified 4 key miRNAs that may be involved in the progression of HFpEF, including hsa-miR-645, hsa-miR-296-5p, hsa-miR-199b-5p, and hsa-miR-509-3-5p. We validated these miRNAs based on their expression, and the ROC plots suggest that these miRNAs may have diagnostic capability in HFpEF. The results of GO and KEGG enrichment analyses showed that the target genes of the differentiated miRNAs were mainly enriched in the MAPK signaling pathway, mTOR signaling pathway, protein processing in endoplasmic reticulum, hippo signaling pathway, cell cycle, Foxo signaling pathway, hypertrophic cardiomyopathy, dilated cardiomyopathy, and circadian rhythm. The mRNA-miRNA interaction networks suggested that TMEM135 was regulated by both has-miR-199b-5p and hsa-miR-296-5p. The RT-PCR results also suggested that miR-199b-5p was upregulated in the HFpEF mice. Conclusion We validated 4 circulating miRNAs with strong correlation to HFpEF, which provide a more reliable basis for pre-symptomatic diagnosis.

The diagnostic values of circulating microRNAs for hypertension and bioinformatic analysis.

The Diagnostic Values Of Circulating Mirnas For Hypertension And Bioinformatics Analysis

Potential diagnostic value of circulating miRNAs in HFrEF and bioinformatics analysis

Integrated Analysis of miRNA and mRNA Regulation Network in Hypertension

Circulating Mir-3135B and Mir-107 Are Potential Biomarkers for Severe Hypertension

Peripheral Blood miRNA Expression in Patients with Essential Hypertension in the Han Chinese Population in Hefei, China

Analysis of Plasma Mir-208A and Mir-370 Expression Levels for Early Diagnosis of Coronary Artery Disease

Transcriptome Analysis of Arterial and Venous Circulating Mirnas During Hypertension

Identification and validation of circulating microRNAs as biomarkers for heart failure with preserved ejection fraction

Abstract P640: Endogenous Micrornas in Human Microvascular Endothelial Cells Regulate Mrnas Encoded by Hypertension-Related Genes and Are Functionally Important

Expression profiles and potential functions of microRNAs in heart failure patients from the Uyghur population

Expression profiles and bioinformatic analysis of microRNAs in myocardium of diabetic cardiomyopathy mice

Several Circulating Mirnas Related to Hyperlipidemia and Atherosclerotic Cardiovascular Diseases

A panel of two miRNAs correlated to systolic blood pressure is a good diagnostic indicator for stroke

Circulating MicroRNA-505 May Serve as a Prognostic Biomarker for Hypertension-Associated Endothelial Dysfunction and Inflammation

The transcriptome of circulating cells indicates potential biomarkers and therapeutic targets in the course of hypertension-related myocardial infarction

Identification of Hub Genes Associated with Hypertension and Their Interaction with Mirna Based on Weighted Gene Coexpression Network Analysis (WGCNA) Analysis.

Combination of PBMC Mir-19B-5p, Mir-221, Mir-25-5p and Hypertension Correlates with Increased Risk of Heart Failure in Coronary Heart Disease Patients

A Machine Learning Model Based on microRNAs for the Diagnosis of Essential Hypertension

Differential Expression of Microrna in Endothelial Cells Incubated with Serum of Hypertension Patients with Blood-Stasis Syndrome

Circulating Mirna29 Family Expression Levels in Patients with Essential Hypertension As Potential Markers for Left Ventricular Hypertrophy